Efficacy and Safety of Upadacitinib in Patients with Active Ankylosing Spondylitis: 1-Year Results from a Randomized, Double-Blind, Placebo-Controlled Study with Open-Label Extension

被引：0

作者：

Deodhar, Atul ^{[1
]}

van der Heijde, Desiree ^{[2
]}

Sieper, Joachim ^{[3
]}

Van den Bosch, Filip ^{[4
]}

Maksymowych, Walter ^{[5
]}

Kim, Tae-Hwan ^{[6
]}

Kishimoto, Mitsumasa ^{[7
]}

Ostor, Andrew ^{[8
]}

Combe, Bernard ^{[9
]}

Sui, Yunxia ^{[10
]}

Wang, Xin ^{[10
]}

Chu, Alvina D. ^{[10
]}

Song, In-Ho ^{[10
]}

机构：

[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[2] Leiden Univ, Med Ctr, Leiden, Netherlands

[3] Charite Univ Med Berlin, Berlin, Germany

[4] Ghent Univ Hosp, Ghent, Belgium

[5] Univ Alberta, Edmonton, AB, Canada

[6] Hanyang Univ Hosp Rheumat Dis, Seoul, South Korea

[7] Kyorin Univ, Dept Nephrol & Rheumatol, Sch Med, Tokyo, Japan

[8] Monash Univ, Cabrini Med Ctr, Malvern, Vic, Australia

[9] Univ Montpellier, Montpellier, France

[10] AbbVie Inc, N Chicago, IL USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2023

引用

页数：4

共 50 条

[1] EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 1-YEAR RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH OPEN-LABEL EXTENSION
Deodhar, A.
Van der Heijde, D.
Sieper, J.
Van den Bosch, F.
Maksymowych, W. P.
Kim, T. H.
Kishimoto, M.
Ostor, A.
Combe, B.
Sui, Y.
Wang, X.
Chu, A.
Song, I. H.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 85 - 86
[2] Efficacy and Safety of Upadacitinib in Patients With Active Ankylosing Spondylitis: 1-Year Results From a Randomized, Double-Blind, Placebo-Controlled Study With Open-Label Extension
Maksymowych, Walter
van der Heijde, Desiree
Sieper, Joachim
van den Bosch, Filip
Kim, Tae-Hwan
Kishimoto, Mitsumasa
Ostor, Andrew
Combe, Bernard
Sui, Yunxia
Wang, Xin
Chu, Alvina
Song, In-Ho
Deodhar, Atul
JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1122 - 1122
[3] EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 2-YEAR RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH OPEN-LABEL EXTENSION
van der Heijde, Desiree
Deodhar, Atul
Maksymowych, Walter P.
Sieper, Joachim
van den Bosch, Filip
Kim, Tae-Hwan
Kishimoto, Mitsumasa
Ostor, Andrew
Combe, Bernard
Sui, Yunxia
Duan, Yuanyuan
Chu, Alvina D.
Song, In-Ho
INTERNAL MEDICINE JOURNAL, 2022, 52 : 26 - 26
[4] Efficacy and Safety of Upadacitinib in Patients with Active Ankylosing Spondylitis: 2-Year Results from a Randomized, Double-Blind, Placebo-Controlled Study with Open-Label Extension
van der Heijde, Desiree
Deodhar, Atul
Maksymowych, Walter
Sieper, Joachim
Van den Bosch, Filip
Kim, Tae-Hwan
Kishimoto, Mitsumasa
Ostor, Andrew
Combe, Bernard
Sui, Yunxia
Duan, Yuanyuan
Chu, Alvina D.
Song, In-Ho
ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1925 - 1928
[5] Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension
van der Heijde, Desiree
Deodhar, Atul
Maksymowych, Walter P.
Sieper, Joachim
Van den Bosch, Filip
Kim, Tae-Hwan
Kishimoto, Mitsumasa
Ostor, Andrew J.
Combe, Bernard
Sui, Yunxia
Duan, Yuanyuan
Wung, Peter K.
Song, In-Ho
RMD OPEN, 2022, 8 (02):
[6] Safety and Efficacy of Upadacitinib in Patients With Active Ankylosing Spondylitis and an Inadequate Response to Nonsteroidal Antiinflammatory Drug Therapy: One-Year Results of a Double-Blind, Placebo-Controlled Study and Open-Label Extension
Deodhar, Atul
van der Heijde, Desiree
Sieper, Joachim
Van den Bosch, Filip
Maksymowych, Walter P.
Kim, Tae-Hwan
Kishimoto, Mitsumasa
Ostor, Andrew
Combe, Bernard
Sui, Yunxia
Chu, Alvina D.
Song, In-Ho
ARTHRITIS & RHEUMATOLOGY, 2022, 74 (01) : 70 - 80
[7] Safety and efficacy of golimumab in Chinese patients with active ankylosing spondylitis: 1-year results of a multicentre, randomized, double-blind, placebo-controlled phase III trial
Bao, Chunde
Huang, Feng
Khan, Muhammad Asim
Fei, Kaiyin
Wu, Zhong
Han, Chenglong
Hsia, Elizabeth C.
RHEUMATOLOGY, 2014, 53 (09) : 1654 - 1663
[8] Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study
Xenofon Baraliakos
Désirée van der Heijde
Joachim Sieper
Robert D. Inman
Hideto Kameda
Yihan Li
Xianwei Bu
Anna Shmagel
Peter Wung
In-Ho Song
Atul Deodhar
Arthritis Research & Therapy, 25
[9] Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study
Baraliakos, Xenofon
van der Heijde, Desiree
Sieper, Joachim
Inman, Robert D.
Kameda, Hideto
Li, Yihan
Bu, Xianwei
Shmagel, Anna
Wung, Peter
Song, In-Ho
Deodhar, Atul
ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
[10] Efficacy and Safety of Upadacitinib in a Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2/3 Clinical Study of Patients with Active Ankylosing Spondylitis
van der Heijde, Desiree
Song, In-Ho
Pangan, Aileen
Deodhar, Atul
Van den Bosch, Filip
Maksymowych, Walter P.
Kim, Tae-Hwan
Kishimoto, Mitsumasa
Everding, Andrea
Sui, Yunxia
Wang, Xin
Chu, Alvina D.
Sieper, Joachim
ARTHRITIS & RHEUMATOLOGY, 2019, 71

← 1 2 3 4 5 →